Newsletter
The FDA Super Bowl

Tradeoffs

The FDA Super Bowl

February 17, 2022

The FDA Super Bowl

Every 5 years, the FDA has to renegotiate billions of dollars in user fees with the drug and medical device companies it regulates. This is one of those years, and Congress has to pass the latest user fee agreements by the end of September to keep FDA running. We break down this controversial process and what other health policies could pass in its wake.

Guest:

Sarah Karlin-Smith, Senior Writer, Pink Sheet

Read a full transcript and dig deeper into the issues explored in today’s episode on our website.

Support this type of journalism today by making a donation.

Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff.

Follow us on Twitter.


See acast.com/privacy for privacy and opt-out information.

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
How To… DIY Climate Action So you want to start infusing climate best practices into your workflow and ensure climate becomes a part of your protocol or criteria – but how?!